NewsNation on MSN

FDA receives applications for generic Mounjaro, Zepbound

Eli Lilly currently holds a patent on both drugs through 2036.
Healthline

Generic Mounjaro, Zepbound May Be Coming, Rivaling Current GLP-1s

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...
RAPS

GDUFA II: FDA Looks to Speed Up Generic Drug Approval Process

On 21 October, the US Food and Drug Administration (FDA) will meet to discuss plans for the second iteration of the Generic Drug User Fee Act (GDUFA II) under which FDA says it will begin offering ...
Health AffairsOpinion

The Supreme Court Protected Generics. Now FDA Must Navigate The Aftermath

The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves ...
Forbes

Canada Approves Generic GLP-1—Here’s The Difference Between Generic And Compounded Formulas

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
NDTV Profit on MSN

Canada approves first generic Wegovy: What it means for weight-loss drug prices

Semaglutide-based drugs, including Novo Nordisk's Ozempic and Wegovy, have seen explosive global demand in recent years for ...
JD Supra

Patenting the Drug Label: Protecting the Full Scope of Your Commercial Product

When life sciences startups think about patent strategy, the natural instinct is to focus on the core science — the novel compound, the ...